Bluebird Bio (BLUE) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
| Debt/EBITDA | 1.07 | 0.38 | -0.87 | -0.65 | -1.89 | -0.94 | ||
| Changes by years, y/y, % | -21% | -65% | -330% | -25% | +191% | |||
Bluebird Bio. Debt/EBITDA
Bluebird Bio. Debt/EBITDA, changes, %
Bluebird Bio (BLUE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| Debt/EBITDA | -0.41 | -0.93 | -1.36 | -1.88 | -0.94 | -0.94 | ||
| Changes by years, y/y, % | +14% | +42% | +3% | +359% | ||||
| Changes by quarters, q/q, % | -46% | +127% | +46% | +38% | -50% | |||